Contineum Therapeutics (NASDAQ:CTNM) Now Covered by Analysts at William Blair
William Blair assumed coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a report released on Friday, MarketBeat reports. The brokerage set an “outperform” rating on the stock. Several other research firms also recently issued reports on CTNM. Morgan Stanley dropped their price target on shares of Contineum Therapeutics from $25.00 to […]
William Blair assumed coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a report released on Friday, MarketBeat reports. The brokerage set an “outperform” rating on the stock. Several other research firms also recently issued reports on CTNM. Morgan Stanley dropped their price target on shares of Contineum Therapeutics from $25.00 to […]
